Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN) | British Journal of Cancer
Prevalence characteristics of human papillomavirus (HPV) infection among women receiving physical examinations in the Shangcheng District, Hangzhou city, China | Scientific Reports
Frontiers | Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer
Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia | Virology Journal | Full Text
Efficient combination of Human Papillomavirus Genotyping for the triage of women with Atypical Squamous Cells of Undetermined Significance in Chinese rural population: A population-based study
Secondary Prevention of Uterine Cervical Cancer | IntechOpen
HPV prevalence and HPV-related dysplasia in elderly women | PLOS ONE
175 Cervical Cancer Screening and HPV - The Curbsiders
Distribution of High-Risk Human Papillomavirus Genotypes among HIV-Negative Women with and without Cervical Intraepithelial Neoplasia in South Africa | PLOS ONE
Prognostic impact of human papillomavirus infection on cervical dysplasia, cancer, and patient survival in Saudi Arabia: A 10-year retrospective analysis | Annals of Saudi Medicine
Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to
We're on the way to ending cervical cancer | MDedge ObGyn
Adjuvant HPV vaccination lowers risk for high-grade cervical dysplasia recurrence
HPV 16 18 45: The Must Read Guide For High-Risk HPV Strains | Papillex®
Viruses | Free Full-Text | Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines
Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia | Virology Journal | Full Text
efficacy after 15 months against CIN attributed to HPV-16/18, by... | Download Scientific Diagram
A high prevalence of human papillomavirus 16 and 18 co-infections in cervical biopsies from southern Brazil | Brazilian Journal of Microbiology
HPV genotype-specific risk for cervical cancer
Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women - The Lancet
Genotypes In Cervical Intraepithelial Neoplasia | IDR
Genital Human Papillomavirus Infection. A Growing Health Risk - Journal of Obstetric, Gynecologic & Neonatal Nursing
Human Papillomavirus Type 51 - an overview | ScienceDirect Topics
Cumulative risk of CIN 2/3 after infection with HPV 16 or 18, or other... | Download Scientific Diagram
Use of various contraceptives and human papillomavirus 16 and 18 infections in women with cervical intraepithelial neoplasia - V Gavrić-Lovrec, I Takač, 2010
The Role of Human Papillomavirus in Cervical Cancer
